Raloxifene [orch, phsu]
Favorable [qlco]
effects [qlco]
Metabolic [ftcn]
Parameters [fndg]
Left Ventricular Function [ortf]
postmenopausal [tmco]
Women [popg]
Study, Prospective [resa]
randomized [resa]
investigated [ftcn]
Raloxifene [orch, phsu]
Echocardiography [diap]
Parameters [fndg]
Left Ventricle [bpoc]
Diastolic [clna]
Systolic [tmco]
function [phsf]
Blood [tisu]
Lipids [lipd]
homocysteine [aapp, bacs]
Lipoprotein (a) [aapp, bacs]
postmenopausal [tmco]
Patients [podg]
Compared [acty]
treated [topp]
Risedronate [orch, phsu]
Women [popg]
included [ftcn]
Study [mnob]
Patients [podg]
randomized [resa]
Group [idcn]
twenty [orch, phsu]
Patients [podg]
Received [qlco]
Raloxifene 60 MG [clnd]
Group 1 [inpr]
Patients [podg]
Received [qlco]
Risedronate [orch, phsu]
mg day [qnco]
Group 2 [inpr]
Control Group [grup]
Patients [podg]
Quantitative [qnco]
2-Dimensional [spco]
Pulsed [phpr]
wave [npop]
Doppler [diap]
Tissue [tisu]
Echocardiography, Doppler [diap]
Levels [qlco]
Fasting [fndg]
Triglycerides [bacs, lipd]
homocysteine [aapp, bacs]
Lipoprotein (a) [aapp, bacs]
Measured [qlco]
Echocardiography [diap]
Biochemical [ftcn]
Parameters [fndg]
Assessed [acty]
Beginning [tmco]
Study [mnob]
demographic [ocdi]
Characteristics [qlco]
baseline [bodm]
Metabolic [ftcn]
Echocardiography [diap]
Parameters [fndg]
Group [idcn]
months [tmco]
therapy [ftcn]
homocysteine [aapp, bacs]
Decreased [qnco]
P NOS [aapp, imft]
P NOS [aapp, imft]
P NOS [aapp, imft]
treated [topp]
Group [idcn]
Compared [acty]
Control Group [grup]
Echocardiography [diap]
measurements [ftcn]
A wave [orga]
Basal [spco]
Interventricular septum [bpoc]
Group [idcn]
Before [tmco]
therapy [ftcn]
Control Group [grup]
A wave [orga]
Basal [spco]
Interventricular septum [bpoc]
Increased [qnco]
P NOS [aapp, imft]
Conclusions [idcn]
Raloxifene [orch, phsu]
Decrease [qlco]
homocysteine [aapp, bacs]
postmenopausal [tmco]
Patients [podg]
Raloxifene [orch, phsu]
therapy [ftcn]
Left Ventricle [bpoc]
Systolic [tmco]
Diastolic [clna]
function [phsf]
LTD [ortf]
Reserve [acty]
